4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-020818
President and CEO sold 4,461 shares at an average $0.47 ($2,103)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lucchino David L. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-13 | Sale : show line 1 in the form 10b5-1 | −2,646 | $0.39 | $1,032 | 707,397 | D |
| 2023-07-14 | Sale : show line 2 in the form 10b5-1 | −1,815 | $0.59 | $1,071 | 705,582 | D |
| Open-market sales · 4,461 sh · avg $0.47 · $2,103 | ||||||
Loading xslF345X05/form4.xml…